Ultimate magazine theme for WordPress.

NPA immunises employees against meningitis

Rep. Managing Director Glaxosmithkline Pharmaceutical Nig. Ltd. Dr. Omolabake
Okunubi; Rep. Managing Director of Nigerian Ports Authority, Abdullahi Goje;
and General Manager Medical Services, Dr. Chinwe Abama at the flag-off vaccination
of all NPA employees against meningitis at the NPA corporate headquarters,
Nigerian Ports Authority (NPA) has embarked on an immunisation exercise for all
its employees, in line with advice by the World Health Organisation to prevent
the spread of meningitis in the West African countries.

Managing Director of Nigerian Ports Authority, Mallam Habib Abdullahi, while
flagging off the ceremony, reiterated the NPA’s commitment to the well-being of its

The Managing
Director who was represented by the General Manager, Marine and Operations, Mallam
 Abdullahi  Goje, noted that the authority believes in the
saying that  ‘health is wealth’ and
therefore would make efforts at ensuring that the workforce remained healthy.

 While commending the medical division for their
initiative, Mallam Goje urged the division to spread the programme to all port
locations and the zonal offices of the authority.

 In her welcome address, the General Manager, Medical
Services Dr C.I. Abama, announced the division embarked on the exercise in response
to a call by World Health Organisation (WHO) to prevent the spread of
meningitis in some of West African countries of Senegal, Chad, Mali, Niger, Cameroon
and Nigeria, regarded as meningitis belts.

 Dr. Abama said that meningitis is a serious
infection of the meninges, the protective membranes that surround the brain and
spinal cord, and that GSK Pharmaceuticals is involved in the programme because
it is the manufacturer of meningitis drugs.

listing the benefits of the exercise to include supporting employees well-being,
reduction in absenteeism as a result of referrals, cost control, reduction of
injuries and improving productivity, she thanked the management for its support
for the division’s activities through approvals over the years.

In her
contribution, the representative of Glaxo Smithkline Pharmaceuticals, Dr.
Omolabake Okunubi lauded the efforts of the NPA, adding that the NPA  management 
took a right step in the right direction.

pointed out that about four hundred and fifty [450] million people across
twenty-two [22] African countries are at risk of being infected by the disease
because it is contagious and people are mobile,

She noted it
is cheaper to prevent the disease than to treat   it. Dr. Okunubi urged all NPA employees to
give maximum attention to the programme.

of the ceremony include a brief sensitisation lecture on meningitis delivered
by Dr. Abama and the flag off of the vaccination exercise by the representative
of the Managing Director.
Leave A Reply

Your email address will not be published.